ITUA20162680A1 - Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente - Google Patents

Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente

Info

Publication number
ITUA20162680A1
ITUA20162680A1 ITUA2016A002680A ITUA20162680A ITUA20162680A1 IT UA20162680 A1 ITUA20162680 A1 IT UA20162680A1 IT UA2016A002680 A ITUA2016A002680 A IT UA2016A002680A IT UA20162680 A ITUA20162680 A IT UA20162680A IT UA20162680 A1 ITUA20162680 A1 IT UA20162680A1
Authority
IT
Italy
Prior art keywords
tiosolphonic
sulfamidic
herpes
viruses
bacterial
Prior art date
Application number
ITUA2016A002680A
Other languages
English (en)
Inventor
Raffaello Pompei
Original Assignee
Univ Degli Studi Cagliari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Cagliari filed Critical Univ Degli Studi Cagliari
Priority to ITUA2016A002680A priority Critical patent/ITUA20162680A1/it
Priority to EP17166846.0A priority patent/EP3235511B1/en
Publication of ITUA20162680A1 publication Critical patent/ITUA20162680A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITUA2016A002680A 2016-04-18 2016-04-18 Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente ITUA20162680A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITUA2016A002680A ITUA20162680A1 (it) 2016-04-18 2016-04-18 Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente
EP17166846.0A EP3235511B1 (en) 2016-04-18 2017-04-18 Sulphonamide compounds for use in the treatment of hhv-8-associated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A002680A ITUA20162680A1 (it) 2016-04-18 2016-04-18 Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente

Publications (1)

Publication Number Publication Date
ITUA20162680A1 true ITUA20162680A1 (it) 2017-10-18

Family

ID=56555587

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A002680A ITUA20162680A1 (it) 2016-04-18 2016-04-18 Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente

Country Status (2)

Country Link
EP (1) EP3235511B1 (it)
IT (1) ITUA20162680A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113304158B (zh) * 2021-06-10 2022-10-28 山东省农业科学院畜牧兽医研究所 磺胺甲氧吡嗪在制备预防和/或治疗牛副流感病毒产品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138652A1 (en) * 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating kaposi sarcoma
WO2011053848A1 (en) * 2009-10-30 2011-05-05 Biogenic Innovations, Llc Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138652A1 (en) * 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating kaposi sarcoma
WO2011053848A1 (en) * 2009-10-30 2011-05-05 Biogenic Innovations, Llc Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BEATRIZ GRINSZTEJN ET AL: "Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial", LANCET INFECTIOUS DISEASES, vol. 14, 4 March 2014 (2014-03-04), pages 281 - 290, XP055326106 *

Also Published As

Publication number Publication date
EP3235511A1 (en) 2017-10-25
EP3235511B1 (en) 2018-12-19

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
IL280459A (en) Phosphoramidates for the treatment of hepatitis B virus
DK3458053T3 (da) Anvendelse af riluzol, riluzolprodrugs eller riluzolanaloger med immunterapier til cancerbehandling
ZA201900156B (en) Phosphoramidates for the treatment of hepatitis b virus
DK3364997T3 (da) Aspartoacylase genterapi til behandling af canavans sygdom
MA52506A (fr) Procédés de traitement d'infections par des virus nipah
DK3307262T3 (da) Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
MA44119A (fr) Vecteurs viraux adéno-associés à utiliser dans le traitement de l'amyotrophie spinale
DK3442600T3 (da) ADENOASSOCIERET VIRUSVEKTORFREMFØRING AF ß-SARCOGLYCAN OG MIKRORNA-29 OG BEHANDLING AF MUSKELDYSTROFI
HK1231402A1 (zh) 治療 型肝炎和 型肝炎病毒感染的方法
DK3261642T3 (da) Quinolinderivater til anvendelse ved behandling eller forebyggelse af virusinfektioner
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
EP3212658A4 (en) 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
IL267639A (en) Oncolytic viruses and therapeutic molecules
EP3134423A4 (en) 2' -disubstituted nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use
DK3153511T3 (da) 2-acylaminothiazolderivat til anvendelse i forebyggelsen eller behandlingen af blære- og urinvejssygdomme
EP3463469C0 (en) COMBINATION OF LEDIPASVIR AND SOFOSBUVIR FOR USE IN THE TREATMENT OF HEPATITIS B IN HUMAN
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
DK3454879T3 (da) Hidtil ukendte forbindelser og farmaceutisk anvendelse deraf i behandlingen af kræft
DK3288949T3 (da) Tetrahydrofuran-fusionerede aminohydrothiazin-derivater, som er anvendelige inden for behandling af Alzheimers sygdom
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
ES2660372T8 (es) Sustancias y procedimientos para la utilización en la prevención y/o el tratamiento en la enfermedad de Huntington
HK1257590A1 (zh) 預防和治療藥物性腎損傷的藥物及其用途
ITUA20162680A1 (it) Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente